Insider Monitor Realtime Top 10
  1. Company List - B
  2. BMRN

Insider Trading activities at Biomarin Pharmaceutical Inc (BMRN) , Part 2

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc (BMRN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1048477.

Total stock buying since 2005: $2,433,737.
Total stock sales since 2005: $583,535,292.
Total stock option exercises since 2005: $188,288,866.


 1   2   3   4   5   6   7   8   9   10   11 
28 insiders reported insider trading activities at Biomarin Pharmaceutical Inc (BMRN):
▪ Insider trading activities of Slamon Dennis
▪ Insider trading activities of Aselage Steve
▪ Insider trading activities of Swiedler Stuart J
▪ Insider trading activities of Cooper Jeffrey H
▪ Insider trading activities of Heron Elaine J
▪ Insider trading activities of Starr Christopher M
▪ Insider trading activities of Spiegelman Daniel K
▪ Insider trading activities of Bienaime Jean Jacques
▪ Insider trading activities of Ajer Jeffrey Robert
▪ Insider trading activities of Lewis Alan
▪ Insider trading activities of Davis George Eric
▪ Insider trading activities of Mueller Brian
▪ Insider trading activities of Lapalme Pierre
▪ Insider trading activities of Klein Joseph Iii
▪ Insider trading activities of Hubbard Cristin
▪ Insider trading activities of Guyer Charles Greg
▪ Insider trading activities of Dere Willard H
▪ Insider trading activities of Lawlis V Bryan
▪ Insider trading activities of Sager Erich
▪ Insider trading activities of Kakkis Emil D
▪ Insider trading activities of Grey Michael G
▪ Insider trading activities of Burkhart Erin
▪ Insider trading activities of Fuchs Henry J
▪ Insider trading activities of Alles Mark J
▪ Insider trading activities of Meier Richard A
▪ Insider trading activities of Baffi Robert
▪ Insider trading activities of Wood Mark
▪ Insider trading activities of Pyott David E I

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Biomarin Pharmaceutical Inc (BMRN).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 11,732 $809,525 0 $0
2024 0 $0 255,921 $21,765,611 199,347 $12,744,795
2023 0 $0 291,124 $29,165,285 298,974 $20,261,651
2022 3,625 $314,468 311,275 $27,255,098 253,242 $11,640,873
2021 0 $0 191,799 $15,370,940 178,931 $4,916,104
2020 12,800 $1,005,145 360,561 $39,226,570 301,650 $13,887,132
2019 0 $0 186,014 $16,384,008 131,953 $2,232,548
2018 0 $0 443,177 $39,824,783 396,390 $13,170,758
2017 0 $0 308,037 $28,193,855 265,930 $7,893,265
2016 0 $0 1,279,525 $111,508,495 1,208,448 $28,339,513
2015 0 $0 411,289 $48,410,265 295,446 $6,663,831
2014 0 $0 340,526 $26,836,672 306,781 $7,721,726
2013 0 $0 742,342 $47,391,614 730,412 $15,099,577
2012 0 $0 1,247,954 $51,415,184 1,198,637 $17,833,395
2011 0 $0 332,106 $9,638,946 335,054 $4,369,131
2010 800 $16,062 564,962 $13,310,700 545,102 $7,510,310
2009 26,500 $306,434 74,572 $1,277,220 83,753 $455,350
2008 16,752 $218,171 1,172,420 $39,560,526 973,113 $8,505,589
2007 17,587 $107,335 576,356 $12,583,816 477,563 $3,277,058
2006 35,493 $362,571 184,500 $2,780,052 284,500 $1,766,260
2005 12,000 $103,551 81,142 $826,127 0 $0


Table 3. Detailed insider trading at Biomarin Pharmaceutical Inc (BMRN) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2021-05-07 Mueller Brian (EVP, Chief Financial Officer) Option Ex 6,709 28.23 189,395
2021-05-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 25,000 78.59 1,964,699
2021-05-07 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 25,000 26.49 662,250
2021-05-06 Meier Richard A Sale 5,068 78.38 397,245
2021-05-06 Meier Richard A Option Ex 15,000 26.49 397,350
2021-05-06 Bienaime Jean Jacques (Chief Executive Officer) Sale 25,000 78.35 1,958,775
2021-05-06 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 25,000 26.49 662,250
2021-05-03 Davis George Eric (EVP, General Counsel) Sale 4,673 78.30 365,895
2021-04-30 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 37.46 37,460
2021-04-19 Davis George Eric (EVP, General Counsel) Sale 2,709 79.58 215,582
2021-04-19 Davis George Eric (EVP, General Counsel) Option Ex 2,709 26.49 71,761
2021-04-15 Lawlis V Bryan Sale 7,500 76.90 576,750
2021-04-15 Lawlis V Bryan Option Ex 7,500 26.49 198,675
2021-04-08 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 1,537 78.81 121,130
2021-04-01 Mueller Brian (EVP, Chief Financial Officer) Sale 5,692 76.30 434,299
2021-03-30 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 1,652 74.79 123,553
2021-03-24 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 1,181 76.30 90,110
2021-03-18 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 1,308 77.99 102,010
2021-03-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 7,000 77.10 539,700
2021-03-12 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 7,000 26.49 185,430
2021-03-11 Bienaime Jean Jacques (Chief Executive Officer) Sale 7,000 77.68 543,760
2021-03-11 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 7,000 26.49 185,430
2021-03-05 Grey Michael G Sale 5,000 76.28 381,400
2021-03-05 Grey Michael G Option Ex 5,000 26.49 132,450
2021-02-19 Bienaime Jean Jacques (Chief Executive Officer) Sale 7,000 83.58 585,060
2021-02-19 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 7,000 26.49 185,430
2021-02-18 Bienaime Jean Jacques (Chief Executive Officer) Sale 7,000 85.08 595,560
2021-02-18 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 7,000 26.49 185,430
2021-02-17 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,000 84.54 676,320
2021-02-17 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 8,000 26.49 211,920
2021-02-16 Lawlis V Bryan Sale 7,500 87.41 655,575
2021-02-16 Lawlis V Bryan Option Ex 7,500 26.49 198,675
2021-01-29 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,334 82.67 688,971
2021-01-29 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 8,334 26.49 220,767
2021-01-28 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,333 82.91 690,889
2021-01-28 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 8,333 26.49 220,741
2021-01-27 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,333 85.49 712,388
2021-01-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 8,333 26.49 220,741
2020-12-29 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 88.18 132,270
2020-12-28 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 88.77 133,155
2020-10-14 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 2,121 79.91 169,489
2020-10-07 Heron Elaine J Option Ex 15,000 26.49 397,350
2020-08-31 Pyott David E I Buy 12,800 78.53 1,005,145
2020-08-03 Grey Michael G Sale 2,500 120.35 300,875
2020-08-03 Grey Michael G Option Ex 2,500 26.49 66,225
2020-07-20 Fuchs Henry J (President, Worldwide R&D) Sale 126,389 130.00 16,430,570
2020-07-20 Fuchs Henry J (President, Worldwide R&D) Option Ex 126,389 66.24 8,372,007
2020-07-13 Fuchs Henry J (President, Worldwide R&D) Sale 23,011 130.00 2,991,430
2020-07-13 Fuchs Henry J (President, Worldwide R&D) Option Ex 23,011 66.24 1,524,248
2020-06-26 Dere Willard H Sale 4,430 123.61 547,592
2020-06-19 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 15,000 124.00 1,860,000
2020-06-19 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Option Ex 15,000 63.10 946,500
2020-06-05 Lawlis V Bryan Sale 4,430 107.46 476,047
2020-05-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 20,000 91.72 1,834,400
2020-05-08 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 20,000 21.51 430,200
2020-05-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 88.00 440,000
2020-05-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 21.51 107,550
2020-05-01 Davis George Eric (EVP, General Counsel) Sale 12,504 89.38 1,117,607
2020-05-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 89.38 357,520
2020-05-01 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 21.51 86,040
2020-04-28 Bienaime Jean Jacques (Chief Executive Officer) Sale 20,000 97.58 1,951,600
2020-04-28 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 20,000 21.51 430,200
2020-04-27 Bienaime Jean Jacques (Chief Executive Officer) Sale 20,000 97.73 1,954,600
2020-04-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 20,000 21.51 430,200
2020-04-24 Fuchs Henry J (President, Worldwide R&D) Sale 20,000 96.50 1,930,040
2020-04-20 Fuchs Henry J (President, Worldwide R&D) Sale 17,213 90.00 1,549,170
2020-04-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 79.06 790,600
2020-04-09 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 21.51 215,100
2020-04-08 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 2,407 79.98 192,511
2020-04-07 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 26.49 26,490
2020-04-01 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 1,537 82.00 126,034
2020-03-25 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 1,618 78.47 126,964
2020-03-24 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 2,041 74.36 151,768
2020-03-17 Lawlis V Bryan Sale 3,750 75.39 282,712
2020-03-17 Lawlis V Bryan Option Ex 3,750 21.51 80,662
2020-03-16 Lawlis V Bryan Sale 4,610 76.52 352,757
2020-03-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 89.52 895,200
2020-03-09 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 21.51 215,100
2020-02-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 83.50 835,000
2020-02-03 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 21.51 215,100
2020-01-30 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 21.51 21,510
2020-01-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,000 87.95 703,600
2020-01-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 8,000 21.51 172,080
2020-01-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 84.92 339,680
2020-01-08 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 21.51 86,040
2020-01-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 84.46 253,379
2020-01-07 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 21.51 64,530
2019-12-27 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 86.16 430,800
2019-12-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 21.51 107,550
2019-12-26 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 86.43 259,290
2019-12-26 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 21.51 64,530
2019-12-17 Lawlis V Bryan Sale 3,750 83.36 312,600
2019-12-17 Lawlis V Bryan Option Ex 3,750 21.51 80,662
2019-11-26 Davis George Eric (EVP, General Counsel) Sale 3,190 79.66 254,115
2019-11-22 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 77.60 776,000
2019-11-22 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 21.51 215,100
2019-10-25 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 69.55 347,750
2019-10-25 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 21.51 107,550
2019-09-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 21.51 21,510
2019-09-17 Lawlis V Bryan Sale 3,750 74.47 279,262
2019-09-17 Lawlis V Bryan Option Ex 3,750 21.51 80,662
2019-08-07 Heron Elaine J Option Ex 1,553 63.10 97,994
2019-06-17 Lawlis V Bryan Sale 3,750 81.08 304,050
2019-06-17 Lawlis V Bryan Option Ex 3,750 21.51 80,662
2019-05-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 82.52 825,190
2019-05-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 14.39 143,900
2019-05-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 81.97 327,888
2019-05-09 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-05-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 82.16 328,624
2019-05-08 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-04-26 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 83.48 250,437
2019-04-26 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2019-04-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 21.51 21,510
2019-04-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 89.12 356,480
2019-04-12 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-04-11 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 14.39 14,390
2019-04-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 92.44 277,326
2019-04-08 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2019-04-05 Mueller Brian (SVP, Corporate Controller) Sale 2,953 94.00 277,582
2019-04-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 93.37 280,113
2019-04-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2019-04-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 13,473 89.00 1,199,097
2019-03-27 Lawlis V Bryan Sale 2,150 89.76 192,984
2019-03-27 Lawlis V Bryan Option Ex 2,150 14.39 30,938
2019-03-27 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 100 90.00 9,000
2019-03-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 14.39 14,390
2019-03-26 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 3,656 89.17 326,023
2019-03-25 Davis George Eric (EVP, General Counsel) Sale 3,363 87.86 295,473
2019-03-25 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 87.86 351,440
2019-03-25 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-03-25 Fuchs Henry J (President, Worldwide R&D) Sale 5,932 87.86 521,185
2019-03-21 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 4,519 90.05 406,917
2019-03-19 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 3,728 93.07 346,964
2019-03-19 Davis George Eric (EVP, General Counsel) Sale 7,907 93.92 742,625
2019-03-19 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 14.39 14,390
2019-03-18 Fuchs Henry J (President, Worldwide R&D) Sale 9,597 94.09 902,981
2019-03-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 94.40 377,600
2019-03-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-03-13 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 93.42 280,254
2019-03-13 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2019-03-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 91.44 365,772
2019-03-12 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-03-11 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 88.96 444,780
2019-03-11 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 14.39 71,950
2019-03-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 90.78 363,120
2019-03-07 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-03-04 Fuchs Henry J (President, Worldwide R&D) Sale 2,196 95.00 208,620
2019-02-27 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 91.78 367,120
2019-02-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-02-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 90.12 270,360
 1   2   3   4   5   6   7   8   9   10   11 

Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.



▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month




©2023, insider-monitor.com. All rights reserved.